Follow Sadhna Bokhiria & KIRIA Advisory Partners for human-first insights as drug pipelines, payer strategy, and care models continue to shift
C has now been taking metformin and an SU at maximum doses for 2 years and continues with lifestyle modifications
Patients often use it to support recovery, reduce fatigue, and strengthen overall resilience
As with any drugs that we prescribe, it is important that we stay abreast of newly recognised potential adverse events which may occur with the drugs we use for diabetes and obesity
For weight loss approved 2021, so 5 years
*Correspondence: Baptist Gallwitz, [email protected] This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers